10x Genomics, Inc. reports 5.22% stake
- ARK Investment Management LLC holds 6,028,612 shares
- Catherine D. Wood holds 6,272,998 shares
- Total stake is 5.22% of Class A shares
ARK Investment Management LLC, filed by
TXG
10x Genomics, Inc. SEC filings
Every EDGAR filing for 10x Genomics, Inc. (TXG), newest first, with AI summaries and stories.
- Ticker
- TXG
- CIK
- 1770787
- Latest filing
- Oct 8
Next: earnings expected ~Nov 6 · 10-Q expected ~Nov 9 (deadline Nov 9)
Insider activity
No open-market insider buys in the last 30 days.
Also: 10 open-market sales ($2.5M).
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINESCHEDULE 13G/A10x Genomics, Inc.TXGLIVE ROUTINE410x Genomics, Inc.TXGLIVE 2 insider filings
Shehnaaz Suliman, insider filing for TXG
Show all 2
- 4Insider filing for TXG
- 4Insider filing for TXG
Shehnaaz Suliman, reporting
ROUTINE14410x Genomics, Inc.TXGLIVE Shehnaaz Suliman, planned sale of TXG shares
Shehnaaz Suliman, reporting
ROUTINE410x Genomics, Inc.TXGLIVE Adam Taich, insider filing for TXG
Adam Taich, reporting
ROUTINE14410x Genomics, Inc.TXGLIVE Adam Taich, planned sale of TXG shares
Adam Taich, reporting
ROUTINE410x Genomics, Inc.TXGLIVE John R Stuelpnagel, insider filing for TXG
John R Stuelpnagel, reporting
ROUTINESCHEDULE 13G10x Genomics, Inc.TXGLIVE Ownership stake disclosure by PRICE T ROWE ASSOCIATES INC /MD/
PRICE T ROWE ASSOCIATES INC /MD/, filed by
ROUTINE410x Genomics, Inc.TXGLIVE Serge Saxonov, insider filing for TXG
Serge Saxonov, reporting
ROUTINE14410x Genomics, Inc.TXGLIVE John R Stuelpnagel, planned sale of TXG shares
John R Stuelpnagel, reporting
ROUTINE410x Genomics, Inc.TXGLIVE Serge Saxonov, insider filing for TXG
Serge Saxonov, reporting
ROUTINE14410x Genomics, Inc.TXGLIVE Serge Saxonov, planned sale of TXG shares
Serge Saxonov, reporting
ROUTINE410x Genomics, Inc.TXGLIVE 4 insider filings
Serge Saxonov, insider filing for TXG
Show all 4
- 4Insider filing for TXG
- 4Insider filing for TXG
- 4Insider filing for TXG
- 4Insider filing for TXG
Serge Saxonov, reporting
ROUTINE14410x Genomics, Inc.TXGLIVE 4 Form 144 notices
Adam Taich, planned sale of TXG shares
Show all 4
- 144Planned insider sale of TXG shares
- 144Planned insider sale of TXG shares
- 144Planned insider sale of TXG shares
- 144Planned insider sale of TXG shares
Adam Taich, reporting
ROUTINE410x Genomics, Inc.TXGLIVE Serge Saxonov, insider filing for TXG
Serge Saxonov, reporting
ROUTINE410x Genomics, Inc.TXGLIVE Sarah A. Teichmann, insider filing for TXG
Sarah A. Teichmann, reporting
ROUTINE14410x Genomics, Inc.TXGLIVE Sarah A. Teichmann, planned sale of TXG shares
Sarah A. Teichmann, reporting
ROUTINESCHEDULE 13G/A10x Genomics, Inc.TXGLIVE Ownership stake disclosure by ARK Investment Management LLC (amended)
ARK Investment Management LLC, filed by
ROUTINE14410x Genomics, Inc.TXGLIVE Sarah A. Teichmann, planned sale of TXG shares
Sarah A. Teichmann, reporting
ROUTINE410x Genomics, Inc.TXGLIVE John R Stuelpnagel, insider filing for TXG
John R Stuelpnagel, reporting
ROUTINE14410x Genomics, Inc.TXGLIVE John R Stuelpnagel, planned sale of TXG shares
John R Stuelpnagel, reporting
ROUTINE8-K10x Genomics, Inc.TXGLIVE ROUTINE410x Genomics, Inc.TXGLIVE Serge Saxonov, insider filing for TXG
Serge Saxonov, reporting
ROUTINE410x Genomics, Inc.TXGLIVE Shehnaaz Suliman, insider filing for TXG
Shehnaaz Suliman, reporting
ROUTINE14410x Genomics, Inc.TXGLIVE Shehnaaz Suliman, planned sale of TXG shares
Shehnaaz Suliman, reporting
ROUTINE410x Genomics, Inc.TXGLIVE 6 insider filings
Sarah A. Teichmann, insider filing for TXG
Show all 6
- 4Insider filing for TXG
- 4Insider filing for TXG
- 4Insider filing for TXG
- 4Insider filing for TXG
- 4Insider filing for TXG
- 4Insider filing for TXG
Sarah A. Teichmann, reporting
ROUTINE8-K10x Genomics, Inc.TXGLIVE ROUTINE410x Genomics, Inc.TXGLIVE 3 insider filings
Serge Saxonov, insider filing for TXG
Show all 3
- 4Insider filing for TXG
- 4Insider filing for TXG
- 4Insider filing for TXG
Serge Saxonov, reporting
ROUTINE14410x Genomics, Inc.TXGLIVE Serge Saxonov, planned sale of TXG shares
Serge Saxonov, reporting
ROUTINE14410x Genomics, Inc.TXGLIVE Serge Saxonov, planned sale of TXG shares
Serge Saxonov, reporting
ROUTINE14410x Genomics, Inc.TXGLIVE 2 Form 144 notices
Benjamin J. Hindson, planned sale of TXG shares
Show all 2
- 144Planned insider sale of TXG shares
- 144Planned insider sale of TXG shares
Benjamin J. Hindson, reporting
ROUTINE8-K10x Genomics, Inc.TXGLIVE ROUTINESCHEDULE 13G10x Genomics, Inc.TXGLIVE Ownership stake disclosure by VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC, filed by
ROUTINESCHEDULE 13G10x Genomics, Inc.TXGLIVE Ownership stake disclosure by VANGUARD PORTFOLIO MANAGEMENT LLC
VANGUARD PORTFOLIO MANAGEMENT LLC, filed by
ROUTINEDEFA14A10x Genomics, Inc.TXGLIVE ROUTINEDEF 14A10x Genomics, Inc.TXGLIVE